| | | | Upcoming Events
|
The EMBO Meeting 2010 - Advancing the life sciences
04 September 2010 - 07 September 2010
Barcelona, Spain
Submit late abstracts by 30 July & register until 15 August
Programme includes: presentations by 120 world-class researchers, e.g. Elizabeth Blackburn and Cliff Tabin, 21 workshops spanning the life sciences, stand-alone poster sessions, on-site childcare and plenty of opportunities to meet fellow scientists.
|
|
|
|
Drug Analysis 2010 - Antwerp, Belgium
21 September 2010 - 24 September 2010
This international symposium is organized by the Belgian Society of Pharmaceutical Sciences (BSPS) since 1983 and will cover all aspects of pharmaceutical and biomedical analysis, including emerging domains, such as ‘omics’, process analytical technology and green analysis.
|
|
|
|
Mass Spec Europe, Florence, Italy
09 November 2010 - 10 November 2010
Mass Spec Europe 2010, will build on the success of last years meeting, by delivering more top class speakers, giving their views and expert opinions on the latest, cutting-edge techniques being used within the mass spectrometry sector. Delegates will also benefit three other conferences which it is being co-located with, ensuring a cost effective trip.
|
|
|
|
Advances in Metabolic Profiling, Florence, Italy
09 November 2010 - 10 November 2010
Welcome to the 6th annual Advances in Metabolic Profiling conference and exhibition.
This year's event will be held in the beautiful and historic city of Florence.
The conference will be co-located with Mass Spec Europe, European Biomarkers Summit and Advances in Protein Crystallography. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.
|
|
|
|
Emerging Therapeutic Strategies for Metabolic Disorders
10 November 2010 - 11 November 2010
As levels of obesity in the developed world continue to rise, advanced treatments for diabetes and cardiovascular disease are in constant demand. SMi's conference on Emerging Therapeutic Strategies for Metabolic Disorders will present the pharmaceutical industry with a review of recent developments along with insights into new avenues of research.
|
|
|
| |
| |
|